chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: RV1
Symptoms: Diarrhoea
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of diarrhea in an infant subject of unspecified gender who was vaccinated with ROTARIX (GlaxoSmithKline). On an unspecified date, prior to 22 July 2014, the subject received 2nd dose of ROTARIX (oral, batch number not provided). At an unspecified time after vaccination with ROTARIX, the subject experienced severe diarrhea. The subject was hospitalised and the healthcare professional considered the event was clinically significant (or requiring intervention). At the time of reporting, the outcome of the event was unspecified. The healthcare professional considered the event was related to vaccination with ROTARIX.
Age: 2.0
Sex: M
Vaccine: HEPA
Symptoms: Seizure
Clinical narrative: This spontaneous report was received from a nurse refers to a 2 year old male patient. The patient's medical history, drug reactions or allergies and concurrent conditions were not reported. On 12-AUG-2014, the patient was vaccinated with the first dose of VAQTA, intramuscular, lot number K007791, expiration date 22-AUG-2016, (dose and anatomical location were not reported). On 10-AUG-2015, the patient was vaccinated with the second dose of VAQTA, intramuscular, lot number L009445, expiration date 01-JUN-2017, (dose and anatomical location were not reported). There was no concomitant medication reported. On 13-AUG-2015, the patient experienced seizure (unspecified type). As a result, the patient was admitted to a hospital and was discharged on 15-AUG-2015. The patient was prescribed diazepam (manufacturer unknown) 10mg, rectal suppositories to be administered in the event of another seizure. On 22-AUG-2015, in a follow-up office visit it was reported that the patient had not had another seizure. On an unspecified date in August 2015, the patient recovered from seizure (unspecified type). No product quality issue was involved. Upon internal review, seizure was determined to be medically significant. Additional information has been requested.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: 1.5" x 3" erythematous, firm and warm to touch, at injection site.
Age: 22.0
Sex: F
Vaccine: HEP
Symptoms: Chest pain, Headache, Musculoskeletal stiffness, Nausea, Pain
Clinical narrative: Fever, Vertigo, Nauseousness, Body Aches, Chest Pain. Stiff Neck and Head Ache lasting until now (4 days).
Age: 22.0
Sex: F
Vaccine: HEP
Symptoms: Pyrexia, Vertigo
Clinical narrative: Fever, Vertigo, Nauseousness, Body Aches, Chest Pain. Stiff Neck and Head Ache lasting until now (4 days).
Age: 69.0
Sex: M
Vaccine: HEPA
Symptoms: Balance disorder, Dizziness
Clinical narrative: Dizziness, with head back, or strong eye movement. could me settled when eyes closed and normal head position. Some balance problems when getting up from sitting position. Slowly less over two weeks time. Still some problems.
Age: 84.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site pruritus, Injection site warmth
Clinical narrative: Triage: Patient calling because the injection site of her pneumonia shot is red, hot, and itchy. She states the issue is spreading. She had the injection on Wednesday. Phoned pt. No trouble swallowing or breathing. The center of injection site is light colored The red area is 2-3 inches above elbow and almost goes to inner arm.
Age: 78.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Triage. Pt called regarding pneumonia shot that was given to her last visit 8/28 and she stated that its been swollen and very painful and red. On Saturday she felt like she had a mild fever.
Age: 66.0
Sex: F
Vaccine: PNC13
Symptoms: Erythema, Peripheral swelling
Clinical narrative: Late entry. Patient called 5:45 pm on 8/29 stating the swelling and redness of her am after PCV 13 vaccine was increasing. This was 2nd call today about this. Son called in the am. She was taking Benadryl tid and icing. Advised to be seen in ER or urgent care on Sat.
Age: 46.0
Sex: F
Vaccine: FLUC3, PPV
Symptoms: Erythema, Pain, Swelling
Clinical narrative: PATIENT COMPLAINTS OF SORENESS, SWELLING AND REDNESS THE DAY AFTER VACCINATION ON HER ARM.
Age: 0.33
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Crying, Diarrhoea, Dysphagia, Feeling hot, Insomnia
Clinical narrative: Fever of 99 degrees two hours after vaccines given. Hotness in the head area. From Day 2 until August 29, 2015, had smelly diarrhea and vomiting after every single feeding; increased crying, fussiness; general malaise; struggling to swallow during feedings; sleeplessness at night.
Age: 0.33
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Irritability, Malaise, Pyrexia, Vomiting
Clinical narrative: Fever of 99 degrees two hours after vaccines given. Hotness in the head area. From Day 2 until August 29, 2015, had smelly diarrhea and vomiting after every single feeding; increased crying, fussiness; general malaise; struggling to swallow during feedings; sleeplessness at night.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site mass, Injection site pruritus, Injection site reaction
Clinical narrative: Lump appeared the day after vaccine in the morning. Bullseye appearance appeared the 26th or the 27th and the area started itching at that time.  The reaction is where the immunization was placed.   Patient is treating with Benadryl.
Age: 17.0
Sex: M
Vaccine: HPV9
Symptoms: Incorrect route of drug administration
Clinical narrative: Gardasil was given Sub Q rather than the correct route of IM.
Age: 80.0
Sex: M
Vaccine: FLU3, PNC13
Symptoms: Influenza like illness
Clinical narrative: Flu-like symptoms the next day.
Age: 5.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Rash erythematous
Clinical narrative: Patients parents started to notice red bumps underneath the skin. No other symptoms.
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Injection site pain
Clinical narrative: Soreness at site of injection progressed to pain in left shoulder joint. Arm is no longer sore at injection site.
Age: 50.0
Sex: M
Vaccine: FLU3
Symptoms: Erythema, Rash
Clinical narrative: 5 bumps surrounded by redness on R arm (170mm x 40mm). Pt was monitored for 1 hour after adverse reaction. Pt was administered liquid Zyrtec (10mg). Treated and released.
Age: 8.0
Sex: M
Vaccine: DTAPIPV, HEP, IPV, VARCEL
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: None.
Age: 11.0
Sex: M
Vaccine: HPV9, MNQ, TDAP
Symptoms: Cellulitis
Clinical narrative: Cellulitis of right arm.
Age: 31.0
Sex: F
Vaccine: FLU3
Symptoms: Eye discharge, Eye pain, Eyelid margin crusting
Clinical narrative: Pt reported feeling eye pain about 30 min. after vaccination. When falling asleep she felt as if her right eye was crusty and it hurt really bad. When she woke up the following morning, her eyes was crusted over with a white discharge. Also per pt, full deltoid muscle usually swells up.
Age: 3.0
Sex: M
Vaccine: BCG
Symptoms: Flushing, Generalised erythema, Injection site urticaria, Irritability, Pyrexia
Clinical narrative: Hives all around site of injection going towards trunk. Fever of 103.9, very fussy and flushed red everywhere.
Age: 86.0
Sex: F
Vaccine: FLU3, PNC13, FLU3, PNC13
Symptoms: Contusion, Decreased appetite, Dysarthria, Feeling abnormal, Injection site bruising
Clinical narrative: On last Wednesday (8/26/15), went to pharmacy and got a flu shot as well as a Prevnar. The flu shot hurt.  Area throbbed.  Took ibuprofen and iced it.  Could not sleep. Her daughter said she was slurring her words after taking some Benadryl.  Refused to come in 8/27/15. Vicodin helped with her pain.  Took it every four hours.  Then took T3 from her son the doctor.  Vomited once on Saturday after taking the T3.  In total, she has taken about seven of them as two last about 24 hours.  Now she feels "lousy."  Her arm hurt this morning before she took the T3.  The area of the shot is slowly getting better, but she feels nauseated and doesn't feel like eating. Left shoulder deltoid area -  23 by 12 cm erythematous area with a large blebs of fluid under the skin.  Central bruise  is mild - ? from the injection site. Reaction after flu shot  - this is quite a response to the flu shot.  Possible cellulitis.  Will treat with keflex 500 mg tid x 5 days.  Discontinue T3, as it may be causing the nausea.  Go back to Vicodin 5/325 if absolutely needs an opiate at all.  Aim for 1/2 tab as rarely as possible.  Ice the area.  I will see her back on Friday, 9/4/15, unless it is completely resolved.  She will call me if the area of redness extends beyond the line I drew on her shoulder.
Age: 86.0
Sex: F
Vaccine: FLU3, PNC13, FLU3, PNC13
Symptoms: Injection site erythema, Injection site pain, Insomnia, Nausea, Pain in extremity
Clinical narrative: On last Wednesday (8/26/15), went to pharmacy and got a flu shot as well as a Prevnar. The flu shot hurt.  Area throbbed.  Took ibuprofen and iced it.  Could not sleep. Her daughter said she was slurring her words after taking some Benadryl.  Refused to come in 8/27/15. Vicodin helped with her pain.  Took it every four hours.  Then took T3 from her son the doctor.  Vomited once on Saturday after taking the T3.  In total, she has taken about seven of them as two last about 24 hours.  Now she feels "lousy."  Her arm hurt this morning before she took the T3.  The area of the shot is slowly getting better, but she feels nauseated and doesn't feel like eating. Left shoulder deltoid area -  23 by 12 cm erythematous area with a large blebs of fluid under the skin.  Central bruise  is mild - ? from the injection site. Reaction after flu shot  - this is quite a response to the flu shot.  Possible cellulitis.  Will treat with keflex 500 mg tid x 5 days.  Discontinue T3, as it may be causing the nausea.  Go back to Vicodin 5/325 if absolutely needs an opiate at all.  Aim for 1/2 tab as rarely as possible.  Ice the area.  I will see her back on Friday, 9/4/15, unless it is completely resolved.  She will call me if the area of redness extends beyond the line I drew on her shoulder.
Age: 86.0
Sex: F
Vaccine: FLU3, PNC13, FLU3, PNC13
Symptoms: Vomiting
Clinical narrative: On last Wednesday (8/26/15), went to pharmacy and got a flu shot as well as a Prevnar. The flu shot hurt.  Area throbbed.  Took ibuprofen and iced it.  Could not sleep. Her daughter said she was slurring her words after taking some Benadryl.  Refused to come in 8/27/15. Vicodin helped with her pain.  Took it every four hours.  Then took T3 from her son the doctor.  Vomited once on Saturday after taking the T3.  In total, she has taken about seven of them as two last about 24 hours.  Now she feels "lousy."  Her arm hurt this morning before she took the T3.  The area of the shot is slowly getting better, but she feels nauseated and doesn't feel like eating. Left shoulder deltoid area -  23 by 12 cm erythematous area with a large blebs of fluid under the skin.  Central bruise  is mild - ? from the injection site. Reaction after flu shot  - this is quite a response to the flu shot.  Possible cellulitis.  Will treat with keflex 500 mg tid x 5 days.  Discontinue T3, as it may be causing the nausea.  Go back to Vicodin 5/325 if absolutely needs an opiate at all.  Aim for 1/2 tab as rarely as possible.  Ice the area.  I will see her back on Friday, 9/4/15, unless it is completely resolved.  She will call me if the area of redness extends beyond the line I drew on her shoulder.
Age: 86.0
Sex: F
Vaccine: FLU3, PNC13, FLU3, PNC13
Symptoms: Vaccination site cellulitis
Clinical narrative: On last Wednesday (8/26/15), went to pharmacy and got a flu shot as well as a Prevnar. The flu shot hurt.  Area throbbed.  Took ibuprofen and iced it.  Could not sleep. Her daughter said she was slurring her words after taking some Benadryl.  Refused to come in 8/27/15. Vicodin helped with her pain.  Took it every four hours.  Then took T3 from her son the doctor.  Vomited once on Saturday after taking the T3.  In total, she has taken about seven of them as two last about 24 hours.  Now she feels "lousy."  Her arm hurt this morning before she took the T3.  The area of the shot is slowly getting better, but she feels nauseated and doesn't feel like eating. Left shoulder deltoid area -  23 by 12 cm erythematous area with a large blebs of fluid under the skin.  Central bruise  is mild - ? from the injection site. Reaction after flu shot  - this is quite a response to the flu shot.  Possible cellulitis.  Will treat with keflex 500 mg tid x 5 days.  Discontinue T3, as it may be causing the nausea.  Go back to Vicodin 5/325 if absolutely needs an opiate at all.  Aim for 1/2 tab as rarely as possible.  Ice the area.  I will see her back on Friday, 9/4/15, unless it is completely resolved.  She will call me if the area of redness extends beyond the line I drew on her shoulder.
Age: 86.0
Sex: F
Vaccine: FLU3, PNC13, FLU3, PNC13
Symptoms: Contusion, Decreased appetite, Dysarthria, Feeling abnormal, Injection site bruising
Clinical narrative: Per provider office, patient developed cellulitis at arm where vaccine site was administered.
Age: 86.0
Sex: F
Vaccine: FLU3, PNC13, FLU3, PNC13
Symptoms: Injection site erythema, Injection site pain, Insomnia, Nausea, Pain in extremity
Clinical narrative: Per provider office, patient developed cellulitis at arm where vaccine site was administered.
Age: 86.0
Sex: F
Vaccine: FLU3, PNC13, FLU3, PNC13
Symptoms: Vomiting
Clinical narrative: Per provider office, patient developed cellulitis at arm where vaccine site was administered.
Age: 86.0
Sex: F
Vaccine: FLU3, PNC13, FLU3, PNC13
Symptoms: Vaccination site cellulitis
Clinical narrative: Per provider office, patient developed cellulitis at arm where vaccine site was administered.
Age: 47.0
Sex: M
Vaccine: TDAP
Symptoms: Headache
Clinical narrative: SEVERE headache, slept all day Saturday and Sunday with headache.
Age: 11.0
Sex: M
Vaccine: HEPA, HPV9, MNQ, TDAP
Symptoms: Body temperature increased, Erythema, Peripheral swelling, Skin warm
Clinical narrative: Pt's mother emailed stating that her son's left arm was red, swollen and hot to the touch. Pt had a temperature of 99.0.
Age: 6.0
Sex: M
Vaccine: DTAP, IPV, VARCEL
Symptoms: Malaise, Pyrexia, Rash generalised, Varicella post vaccine
Clinical narrative: Per Mother of child: Developed fever and malaise, few chicken pox spots noted. 8/28/15 fever continued, rash continued. 8/29/15 fever up to 103.5 and generalized rash. Fever controlled with ibuprofen. Referred to PCP for further evaluation and documentation.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Mobility decreased, Pain, Pain in extremity, Tenderness
Clinical narrative: Experienced general soreness and redness later that day after receiving vaccine. A little less than 24 hours after receiving vaccination (Prevnar 13), patient experienced extreme pain in arm and was unable to move arm. Felt pain and tenderness in the area. Pain lasted for about 3 days, decreasing in quality every day until the 4th day where patient felt better.
Age: 10.0
Sex: M
Vaccine: HEPA
Symptoms: Cold sweat, Confusional state, Fall, Presyncope, Seizure
Clinical narrative: Within a few minutes of vaccine, noted to be slumped over and having generalized tonic clonic movements of upper and lower extremities. Lasted about 15 seconds. Woke, clammy and confused. Laid down and rested and was ok about 10 min later. Suspect vasovagal response and then brief seizure.
Age: 10.0
Sex: M
Vaccine: HEPA
Symptoms: Tonic clonic movements
Clinical narrative: Within a few minutes of vaccine, noted to be slumped over and having generalized tonic clonic movements of upper and lower extremities. Lasted about 15 seconds. Woke, clammy and confused. Laid down and rested and was ok about 10 min later. Suspect vasovagal response and then brief seizure.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Vaccination site bruising
Clinical narrative: Patient came to Pharmacy to show me she had a black and blue bruise where the vaccine was adminstired. She did not have any pain assoicated with the brusing. She felt completely fine.
Age: 16.0
Sex: F
Vaccine: HPV9
Symptoms: Dizziness, Hypotension, Nausea
Clinical narrative: HYPOTENSIVE, NAUSEA, DIZZINESS, PRE VACCINE BP 113/73, POST VACCINE BP 90/62.
Age: 67.0
Sex: F
Vaccine: PNC13
Symptoms: Lip swelling, Pain in extremity, Pyrexia, Swelling face
Clinical narrative: PUFFY UPPER LIPS, SWOLLEN FACE, SORE ARM AND FEVER.
Age: 69.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Anosmia, Hyposmia, Influenza like illness, Laboratory test, Malaise
Clinical narrative: This medically confirmed literature report (initial receipt 24-Aug-2015) concerns a 69 year-old female patient. On an unspecified date, the patient received Influenza virus vaccine (manufacturer and batch number not provided) via the intramuscular route. On an unspecified date, the patient experienced flu-like symptoms such as malaise, fever, and rhinorrhea within a week after inoculation. The patient did not complain of taste dysfunction. The SIT (Smell Identification Test) score was 16/40 which was not suggestive of malingering (<6). The patient was diagnosed with anosmia. The PEA (phenyl ethyl alcohol) test score was -2.00 bilateral. The Whole-Mouth test identification test score was 80% correct. The outcome was not reported. Reporter's comments: The authors reported that the smell dysfunction was not attributed to any one season's vaccination program and they were presented to the center over the course of 10 years. The patients attributed the chemosensory/olfactory disturbances to an influenza vaccination. As with the SIT and the olfactory tests, neither the influences of ever having had an influenza vaccination nor the total number of lifetime inoculations were associated with the test measures. The present study suggested the possibility that, in rare cases, influenza vaccinations may be associated with olfactory dysfunction. In these patients whose smell loss was attributed to causes other than influenza vaccinations, the magnitude of vaccination influences was too weak to overcome the primary basis for their loss. There were no associations apparent between quantitative smell or taste test scores and reports of having one or more lifetime influenza vaccine inoculations. The benefits of receiving an influenza vaccine would seem to clearly outweigh its potential side effects.
Age: 69.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Olfactory test abnormal, Pyrexia, Rhinorrhoea
Clinical narrative: This medically confirmed literature report (initial receipt 24-Aug-2015) concerns a 69 year-old female patient. On an unspecified date, the patient received Influenza virus vaccine (manufacturer and batch number not provided) via the intramuscular route. On an unspecified date, the patient experienced flu-like symptoms such as malaise, fever, and rhinorrhea within a week after inoculation. The patient did not complain of taste dysfunction. The SIT (Smell Identification Test) score was 16/40 which was not suggestive of malingering (<6). The patient was diagnosed with anosmia. The PEA (phenyl ethyl alcohol) test score was -2.00 bilateral. The Whole-Mouth test identification test score was 80% correct. The outcome was not reported. Reporter's comments: The authors reported that the smell dysfunction was not attributed to any one season's vaccination program and they were presented to the center over the course of 10 years. The patients attributed the chemosensory/olfactory disturbances to an influenza vaccination. As with the SIT and the olfactory tests, neither the influences of ever having had an influenza vaccination nor the total number of lifetime inoculations were associated with the test measures. The present study suggested the possibility that, in rare cases, influenza vaccinations may be associated with olfactory dysfunction. In these patients whose smell loss was attributed to causes other than influenza vaccinations, the magnitude of vaccination influences was too weak to overcome the primary basis for their loss. There were no associations apparent between quantitative smell or taste test scores and reports of having one or more lifetime influenza vaccine inoculations. The benefits of receiving an influenza vaccine would seem to clearly outweigh its potential side effects.
Age: 69.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Anosmia, Influenza like illness, Laboratory test, Malaise, Olfactory test abnormal
Clinical narrative: This medically confirmed literature report (initial receipt 24-Aug-2015) concerns a 69 year-old female patient. On an unspecified date, the patient received Influenza virus vaccine (manufacturer and batch number not provided) via the intramuscular route. On an unspecified date, the patient experienced flu-like symptoms such as malaise, fever, and rhinorrhea within a week after inoculation. The patient did not complain of taste dysfunction. The SIT (Smell Identification Test) score was 16/40 which was not suggestive of malingering (<6). The patient was diagnosed with anosmia. The PEA (phenyl ethyl alcohol) test score was -2.00 bilateral. The Whole-Mouth test identification test score was 80% correct. The outcome was not reported. Reporter's comments: The authors reported that the smell dysfunction was not attributed to any one season's vaccination program and they were presented to the center over the course of 10 years. The patients attributed the chemosensory/olfactory disturbances to an influenza vaccination. As with the SIT and the olfactory tests, neither the influences of ever having had an influenza vaccination nor the total number of lifetime inoculations were associated with the test measures. The present study suggested the possibility that, in rare cases, influenza vaccinations may be associated with olfactory dysfunction. In these patients whose smell loss was attributed to causes other than influenza vaccinations, the magnitude of vaccination influences was too weak to overcome the primary basis for their loss. There were no associations apparent between quantitative smell or taste test scores and reports of having one or more lifetime influenza vaccine inoculations. The benefits of receiving an influenza vaccine would seem to clearly outweigh its potential side effects.
Age: 69.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Pyrexia, Rhinorrhoea
Clinical narrative: This medically confirmed literature report (initial receipt 24-Aug-2015) concerns a 69 year-old female patient. On an unspecified date, the patient received Influenza virus vaccine (manufacturer and batch number not provided) via the intramuscular route. On an unspecified date, the patient experienced flu-like symptoms such as malaise, fever, and rhinorrhea within a week after inoculation. The patient did not complain of taste dysfunction. The SIT (Smell Identification Test) score was 16/40 which was not suggestive of malingering (<6). The patient was diagnosed with anosmia. The PEA (phenyl ethyl alcohol) test score was -2.00 bilateral. The Whole-Mouth test identification test score was 80% correct. The outcome was not reported. Reporter's comments: The authors reported that the smell dysfunction was not attributed to any one season's vaccination program and they were presented to the center over the course of 10 years. The patients attributed the chemosensory/olfactory disturbances to an influenza vaccination. As with the SIT and the olfactory tests, neither the influences of ever having had an influenza vaccination nor the total number of lifetime inoculations were associated with the test measures. The present study suggested the possibility that, in rare cases, influenza vaccinations may be associated with olfactory dysfunction. In these patients whose smell loss was attributed to causes other than influenza vaccinations, the magnitude of vaccination influences was too weak to overcome the primary basis for their loss. There were no associations apparent between quantitative smell or taste test scores and reports of having one or more lifetime influenza vaccine inoculations. The benefits of receiving an influenza vaccine would seem to clearly outweigh its potential side effects.
Age: 69.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Hyposmia, Influenza like illness, Malaise, Microsomia, Olfactory test abnormal
Clinical narrative: This medically confirmed literature report (initial receipt 24-Aug-2015) concerns a 69 year-old female patient. On an unspecified date, the patient received Influenza virus vaccine (manufacturer and batch number not provided) via the intramuscular route. On an unspecified date, the patient experienced flu-like symptoms such as malaise, fever, and rhinorrhea within a week after inoculation. The patient did not complain of taste dysfunction. The SIT (Smell Identification Test) score was 28/40 which was not suggestive of malingering (<6). The patient was diagnosed with moderate mircosmia (16th percentile). The PEA (phenyl ethyl alcohol) test scores were -4.75 left, -5.25 right and -6.50 bilateral. The Whole-Mouth test identification test score was 62% correct. The outcome was not reported. Reporter's comments: The authors reported that this was a rare occurrence in an adolescent individual. The smell dysfunction was not attributed to any one season's vaccination program and they were presented to the center over the course of 10 years. The patients attributed the chemosensory/olfactory disturbances to an influenza vaccination. As with the SIT and the olfactory tests, neither the influences of ever having had an influenza vaccination nor the total number of lifetime inoculations were associated with the test measures. The present study suggested the possibility that, in rare cases, influenza vaccinations may be associated with olfactory dysfunction. In these patients whose smell loss was attributed to causes other than influenza vaccinations, the magnitude of vaccination influences was too weak to overcome the primary basis for their loss. There were no associations apparent between quantitative smell or taste test scores and reports of having one or more lifetime influenza vaccine inoculations. The benefits of receiving an influenza vaccine would seem to clearly outweigh its potential side effects.
Age: 69.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Pyrexia, Rhinorrhoea
Clinical narrative: This medically confirmed literature report (initial receipt 24-Aug-2015) concerns a 69 year-old female patient. On an unspecified date, the patient received Influenza virus vaccine (manufacturer and batch number not provided) via the intramuscular route. On an unspecified date, the patient experienced flu-like symptoms such as malaise, fever, and rhinorrhea within a week after inoculation. The patient did not complain of taste dysfunction. The SIT (Smell Identification Test) score was 28/40 which was not suggestive of malingering (<6). The patient was diagnosed with moderate mircosmia (16th percentile). The PEA (phenyl ethyl alcohol) test scores were -4.75 left, -5.25 right and -6.50 bilateral. The Whole-Mouth test identification test score was 62% correct. The outcome was not reported. Reporter's comments: The authors reported that this was a rare occurrence in an adolescent individual. The smell dysfunction was not attributed to any one season's vaccination program and they were presented to the center over the course of 10 years. The patients attributed the chemosensory/olfactory disturbances to an influenza vaccination. As with the SIT and the olfactory tests, neither the influences of ever having had an influenza vaccination nor the total number of lifetime inoculations were associated with the test measures. The present study suggested the possibility that, in rare cases, influenza vaccinations may be associated with olfactory dysfunction. In these patients whose smell loss was attributed to causes other than influenza vaccinations, the magnitude of vaccination influences was too weak to overcome the primary basis for their loss. There were no associations apparent between quantitative smell or taste test scores and reports of having one or more lifetime influenza vaccine inoculations. The benefits of receiving an influenza vaccine would seem to clearly outweigh its potential side effects.
Age: 69.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Anosmia, Influenza like illness, Laboratory test, Malaise, Microsomia
Clinical narrative: This medically confirmed literature report (initial receipt 24-Aug-2015) concerns a 69 year-old female patient. On an unspecified date, the patient received Influenza virus vaccine (manufacturer and batch number not provided) via the intramuscular route. On an unspecified date, the patient experienced flu-like symptoms such as malaise, fever, and rhinorrhea within a week after inoculation. The patient did not complain of taste dysfunction. The SIT (Smell Identification Test) score was 28/40 which was not suggestive of malingering (<6). The patient was diagnosed with moderate mircosmia (16th percentile). The PEA (phenyl ethyl alcohol) test scores were -4.75 left, -5.25 right and -6.50 bilateral. The Whole-Mouth test identification test score was 62% correct. The outcome was not reported. Reporter's comments: The authors reported that this was a rare occurrence in an adolescent individual. The smell dysfunction was not attributed to any one season's vaccination program and they were presented to the center over the course of 10 years. The patients attributed the chemosensory/olfactory disturbances to an influenza vaccination. As with the SIT and the olfactory tests, neither the influences of ever having had an influenza vaccination nor the total number of lifetime inoculations were associated with the test measures. The present study suggested the possibility that, in rare cases, influenza vaccinations may be associated with olfactory dysfunction. In these patients whose smell loss was attributed to causes other than influenza vaccinations, the magnitude of vaccination influences was too weak to overcome the primary basis for their loss. There were no associations apparent between quantitative smell or taste test scores and reports of having one or more lifetime influenza vaccine inoculations. The benefits of receiving an influenza vaccine would seem to clearly outweigh its potential side effects.
Age: 69.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Olfactory test abnormal, Pyrexia, Rhinorrhoea
Clinical narrative: This medically confirmed literature report (initial receipt 24-Aug-2015) concerns a 69 year-old female patient. On an unspecified date, the patient received Influenza virus vaccine (manufacturer and batch number not provided) via the intramuscular route. On an unspecified date, the patient experienced flu-like symptoms such as malaise, fever, and rhinorrhea within a week after inoculation. The patient did not complain of taste dysfunction. The SIT (Smell Identification Test) score was 28/40 which was not suggestive of malingering (<6). The patient was diagnosed with moderate mircosmia (16th percentile). The PEA (phenyl ethyl alcohol) test scores were -4.75 left, -5.25 right and -6.50 bilateral. The Whole-Mouth test identification test score was 62% correct. The outcome was not reported. Reporter's comments: The authors reported that this was a rare occurrence in an adolescent individual. The smell dysfunction was not attributed to any one season's vaccination program and they were presented to the center over the course of 10 years. The patients attributed the chemosensory/olfactory disturbances to an influenza vaccination. As with the SIT and the olfactory tests, neither the influences of ever having had an influenza vaccination nor the total number of lifetime inoculations were associated with the test measures. The present study suggested the possibility that, in rare cases, influenza vaccinations may be associated with olfactory dysfunction. In these patients whose smell loss was attributed to causes other than influenza vaccinations, the magnitude of vaccination influences was too weak to overcome the primary basis for their loss. There were no associations apparent between quantitative smell or taste test scores and reports of having one or more lifetime influenza vaccine inoculations. The benefits of receiving an influenza vaccine would seem to clearly outweigh its potential side effects.
Age: 60.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Hyposmia, Influenza like illness, Malaise, Olfactory test abnormal, Pyrexia
Clinical narrative: This medically confirmed literature report (initial receipt 24-Aug-2015) concerns a 60 year-old male patient. On an unspecified date, the patient received Influenza virus vaccine (manufacturer and batch number not provided) via the intramuscular route. On an unspecified date, the patient experienced flu-like symptoms such as malaise, fever, and rhinorrhea within a week after inoculation. The patient did not complain of taste dysfunction. The SIT (Smell Identification Test) score was 31/40 which was not suggestive of malingering (<6). The patient was diagnosed with mild mircosmia (22nd percentile). The PEA (phenyl ethyl alcohol) test scores were -4.12 left, -3.12 right and -2.70 bilateral. The Whole-Mouth test identification test score was 88% correct. The outcome was not reported. Reporter's comments: The authors reported that this was a rare occurrence in an adolescent individual. The smell dysfunction was not attributed to any one season's vaccination program and they were presented to the center over the course of 10 years. The patients attributed the chemosensory/olfactory disturbances to an influenza vaccination. As with the SIT and the olfactory tests, neither the influences of ever having had an influenza vaccination nor the total number of lifetime inoculations were associated with the test measures. The present study suggested the possibility that, in rare cases, influenza vaccinations may be associated with olfactory dysfunction. In these patients whose smell loss was attributed to causes other than influenza vaccinations, the magnitude of vaccination influences was too weak to overcome the primary basis for their loss. There were no associations apparent between quantitative smell or taste test scores and reports of having one or more lifetime influenza vaccine inoculations. The benefits of receiving an influenza vaccine would seem to clearly outweigh its potential side effects.
Age: 60.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Rhinorrhoea
Clinical narrative: This medically confirmed literature report (initial receipt 24-Aug-2015) concerns a 60 year-old male patient. On an unspecified date, the patient received Influenza virus vaccine (manufacturer and batch number not provided) via the intramuscular route. On an unspecified date, the patient experienced flu-like symptoms such as malaise, fever, and rhinorrhea within a week after inoculation. The patient did not complain of taste dysfunction. The SIT (Smell Identification Test) score was 31/40 which was not suggestive of malingering (<6). The patient was diagnosed with mild mircosmia (22nd percentile). The PEA (phenyl ethyl alcohol) test scores were -4.12 left, -3.12 right and -2.70 bilateral. The Whole-Mouth test identification test score was 88% correct. The outcome was not reported. Reporter's comments: The authors reported that this was a rare occurrence in an adolescent individual. The smell dysfunction was not attributed to any one season's vaccination program and they were presented to the center over the course of 10 years. The patients attributed the chemosensory/olfactory disturbances to an influenza vaccination. As with the SIT and the olfactory tests, neither the influences of ever having had an influenza vaccination nor the total number of lifetime inoculations were associated with the test measures. The present study suggested the possibility that, in rare cases, influenza vaccinations may be associated with olfactory dysfunction. In these patients whose smell loss was attributed to causes other than influenza vaccinations, the magnitude of vaccination influences was too weak to overcome the primary basis for their loss. There were no associations apparent between quantitative smell or taste test scores and reports of having one or more lifetime influenza vaccine inoculations. The benefits of receiving an influenza vaccine would seem to clearly outweigh its potential side effects.
Age: 60.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Anosmia, Influenza like illness, Laboratory test, Malaise, Microsomia
Clinical narrative: This medically confirmed literature report (initial receipt 24-Aug-2015) concerns a 60 year-old male patient. On an unspecified date, the patient received Influenza virus vaccine (manufacturer and batch number not provided) via the intramuscular route. On an unspecified date, the patient experienced flu-like symptoms such as malaise, fever, and rhinorrhea within a week after inoculation. The patient did not complain of taste dysfunction. The SIT (Smell Identification Test) score was 31/40 which was not suggestive of malingering (<6). The patient was diagnosed with mild mircosmia (22nd percentile). The PEA (phenyl ethyl alcohol) test scores were -4.12 left, -3.12 right and -2.70 bilateral. The Whole-Mouth test identification test score was 88% correct. The outcome was not reported. Reporter's comments: The authors reported that this was a rare occurrence in an adolescent individual. The smell dysfunction was not attributed to any one season's vaccination program and they were presented to the center over the course of 10 years. The patients attributed the chemosensory/olfactory disturbances to an influenza vaccination. As with the SIT and the olfactory tests, neither the influences of ever having had an influenza vaccination nor the total number of lifetime inoculations were associated with the test measures. The present study suggested the possibility that, in rare cases, influenza vaccinations may be associated with olfactory dysfunction. In these patients whose smell loss was attributed to causes other than influenza vaccinations, the magnitude of vaccination influences was too weak to overcome the primary basis for their loss. There were no associations apparent between quantitative smell or taste test scores and reports of having one or more lifetime influenza vaccine inoculations. The benefits of receiving an influenza vaccine would seem to clearly outweigh its potential side effects.
Age: 60.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Olfactory test abnormal, Pyrexia, Rhinorrhoea
Clinical narrative: This medically confirmed literature report (initial receipt 24-Aug-2015) concerns a 60 year-old male patient. On an unspecified date, the patient received Influenza virus vaccine (manufacturer and batch number not provided) via the intramuscular route. On an unspecified date, the patient experienced flu-like symptoms such as malaise, fever, and rhinorrhea within a week after inoculation. The patient did not complain of taste dysfunction. The SIT (Smell Identification Test) score was 31/40 which was not suggestive of malingering (<6). The patient was diagnosed with mild mircosmia (22nd percentile). The PEA (phenyl ethyl alcohol) test scores were -4.12 left, -3.12 right and -2.70 bilateral. The Whole-Mouth test identification test score was 88% correct. The outcome was not reported. Reporter's comments: The authors reported that this was a rare occurrence in an adolescent individual. The smell dysfunction was not attributed to any one season's vaccination program and they were presented to the center over the course of 10 years. The patients attributed the chemosensory/olfactory disturbances to an influenza vaccination. As with the SIT and the olfactory tests, neither the influences of ever having had an influenza vaccination nor the total number of lifetime inoculations were associated with the test measures. The present study suggested the possibility that, in rare cases, influenza vaccinations may be associated with olfactory dysfunction. In these patients whose smell loss was attributed to causes other than influenza vaccinations, the magnitude of vaccination influences was too weak to overcome the primary basis for their loss. There were no associations apparent between quantitative smell or taste test scores and reports of having one or more lifetime influenza vaccine inoculations. The benefits of receiving an influenza vaccine would seem to clearly outweigh its potential side effects.
Age: 52.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Hyposmia, Influenza like illness, Laboratory test, Malaise, Microsomia
Clinical narrative: This medically confirmed literature report (initial receipt 24-Aug-2015) concerns a 52 year-old male patient. On an unspecified date, the patient received Influenza virus vaccine (manufacturer and batch number not provided) via the intramuscular route. On an unspecified date, the patient experienced flu-like symptoms such as malaise, fever, and rhinorrhea within a week after inoculation. The patient did not complain of taste dysfunction. The SIT (Smell Identification Test) score was 30/40 which was not suggestive of malingering (<6). The patient was diagnosed with mild mircosmia (18th percentile). The PEA (phenyl ethyl alcohol) test score was -3.62 bilateral. The Whole-Mouth test identification test score was 93% correct. The outcome was not reported. Reporter's comments: The authors reported that this was a rare occurrence in an adolescent individual. The smell dysfunction was not attributed to any one season's vaccination program and they were presented to the center over the course of 10 years. The patients attributed the chemosensory/olfactory disturbances to an influenza vaccination. As with the SIT and the olfactory tests, neither the influences of ever having had an influenza vaccination nor the total number of lifetime inoculations were associated with the test measures. The present study suggested the possibility that, in rare cases, influenza vaccinations may be associated with olfactory dysfunction. In these patients whose smell loss was attributed to causes other than influenza vaccinations, the magnitude of vaccination influences was too weak to overcome the primary basis for their loss. There were no associations apparent between quantitative smell or taste test scores and reports of having one or more lifetime influenza vaccine inoculations. The benefits of receiving an influenza vaccine would seem to clearly outweigh its potential side effects.
Age: 52.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Olfactory test abnormal, Pyrexia, Rhinorrhoea
Clinical narrative: This medically confirmed literature report (initial receipt 24-Aug-2015) concerns a 52 year-old male patient. On an unspecified date, the patient received Influenza virus vaccine (manufacturer and batch number not provided) via the intramuscular route. On an unspecified date, the patient experienced flu-like symptoms such as malaise, fever, and rhinorrhea within a week after inoculation. The patient did not complain of taste dysfunction. The SIT (Smell Identification Test) score was 30/40 which was not suggestive of malingering (<6). The patient was diagnosed with mild mircosmia (18th percentile). The PEA (phenyl ethyl alcohol) test score was -3.62 bilateral. The Whole-Mouth test identification test score was 93% correct. The outcome was not reported. Reporter's comments: The authors reported that this was a rare occurrence in an adolescent individual. The smell dysfunction was not attributed to any one season's vaccination program and they were presented to the center over the course of 10 years. The patients attributed the chemosensory/olfactory disturbances to an influenza vaccination. As with the SIT and the olfactory tests, neither the influences of ever having had an influenza vaccination nor the total number of lifetime inoculations were associated with the test measures. The present study suggested the possibility that, in rare cases, influenza vaccinations may be associated with olfactory dysfunction. In these patients whose smell loss was attributed to causes other than influenza vaccinations, the magnitude of vaccination influences was too weak to overcome the primary basis for their loss. There were no associations apparent between quantitative smell or taste test scores and reports of having one or more lifetime influenza vaccine inoculations. The benefits of receiving an influenza vaccine would seem to clearly outweigh its potential side effects.
Age: 52.0
Sex: M
Vaccine: FLUX, FLUX
Symptoms: Anosmia, Influenza like illness, Laboratory test, Malaise, Microsomia
Clinical narrative: This medically confirmed literature report (initial receipt 24-Aug-2015) concerns a 52 year-old male patient. On an unspecified date, the patient received Influenza virus vaccine (manufacturer and batch number not provided) via the intramuscular route. On an unspecified date, the patient experienced flu-like symptoms such as malaise, fever, and rhinorrhea within a week after inoculation. The patient did not complain of taste dysfunction. The SIT (Smell Identification Test) score was 30/40 which was not suggestive of malingering (<6). The patient was diagnosed with mild mircosmia (18th percentile). The PEA (phenyl ethyl alcohol) test score was -3.62 bilateral. The Whole-Mouth test identification test score was 93% correct. The outcome was not reported. Reporter's comments: The authors reported that this was a rare occurrence in an adolescent individual. The smell dysfunction was not attributed to any one season's vaccination program and they were presented to the center over the course of 10 years. The patients attributed the chemosensory/olfactory disturbances to an influenza vaccination. As with the SIT and the olfactory tests, neither the influences of ever having had an influenza vaccination nor the total number of lifetime inoculations were associated with the test measures. The present study suggested the possibility that, in rare cases, influenza vaccinations may be associated with olfactory dysfunction. In these patients whose smell loss was attributed to causes other than influenza vaccinations, the magnitude of vaccination influences was too weak to overcome the primary basis for their loss. There were no associations apparent between quantitative smell or taste test scores and reports of having one or more lifetime influenza vaccine inoculations. The benefits of receiving an influenza vaccine would seem to clearly outweigh its potential side effects.
Age: 48.0
Sex: F
Vaccine: FLUX, FLUX
Symptoms: Hyposmia, Influenza like illness, Laboratory test, Malaise, Microsomia
Clinical narrative: This medically confirmed literature report (initial receipt 24-Aug-2015) concerns a 48 year-old female patient. On an unspecified date, the patient received Influenza virus vaccine (manufacturer and batch number not provided) via the intramuscular route. On an unspecified date, the patient experienced flu-like symptoms such as malaise, fever, and rhinorrhea within a week after inoculation. The patient did not complain of taste dysfunction. The SIT (Smell Identification Test) score was 34/40 which was not suggestive of malingering (<6). The patient was diagnosed with mild mircosmia (20th percentile). The PEA (phenyl ethyl alcohol) test scores were -5.25 left, -5.75 right and -5.70 bilateral. The Whole-Mouth test identification test score was 73% correct. The outcome was not reported. Reporter's comments: The authors reported that this was a rare occurrence in an adolescent individual. The smell dysfunction was not attributed to any one season's vaccination program and they were presented to the center over the course of 10 years. The patients attributed the chemosensory/olfactory disturbances to an influenza vaccination. As with the SIT and the olfactory tests, neither the influences of ever having had an influenza vaccination nor the total number of lifetime inoculations were associated with the test measures. The present study suggested the possibility that, in rare cases, influenza vaccinations may be associated with olfactory dysfunction. In these patients whose smell loss was attributed to causes other than influenza vaccinations, the magnitude of vaccination influences was too weak to overcome the primary basis for their loss. There were no associations apparent between quantitative smell or taste test scores and reports of having one or more lifetime influenza vaccine inoculations. The benefits of receiving an influenza vaccine would seem to clearly outweigh its potential side effects.